Veeva Systems Inc. (VEEV) Earnings Call Transcripts

55 earnings calls from January 2020 to June 3, 2026

NYSE US Health Care Health Care Technology

Veeva Systems Inc.'s Latest Earnings Call - Q1 FY2027

In Veeva Systems' Fiscal 2027 First Quarter earnings call for the period ending April 30, 2026, the company reported total revenue of $883 million and a non-GAAP operating income of $395 million, both exceeding prior guidance. The strong performance was attributed to robust growth in their R&D and Crossix segments, with management highlighting the disruptive potential of their new AI-driven product, Veeva Falcon. Guidance for the full fiscal year was raised by $5 million, indicating confidence in continued momentum despite a conservative outlook on certain early-stage products.

Reported metrics

MetricValueContext
Total Revenue $883 million (beat) vs $850 million est, +10% YoY
Non-GAAP Operating Income $395 million (beat) vs $370 million est, +12% YoY
Full Year Revenue Guidance Increase $5 million (neutral) raised from previous guidance
Crossix Revenue Growth null (positive) strong performance noted but specific figures not provided
Ostro Contribution $10 million (positive) expected contribution for remaining 3 quarters
Professional Services Revenue null (positive) record quarter but specific figures not disclosed

Guidance from management

Management raised full-year revenue guidance by $5 million, reflecting confidence in continued growth despite some early-stage products still scaling.

What management said

Thank you, Gunnar, and welcome, everyone, to the call. We had a strong start to the year, delivering results ahead of our guidance. Total revenue in the quarter was $883 million with non-GAAP operating income of $395 million. Our execution continues strong across the business. And it's an exciting time for Veeva and for life sciences overall, as we execute against a clear vision for industry AI. We'll now open up t...
— Peter Gassner, Q1 FY2027 earnings call
Yes. Ken, I think first off, we are really happy with the growth of R&D in Q1. It's a healthy business overall in DevCloud and Quality Cloud, very long way to go in that business. I think the main factor you're seeing there is the same dynamic that we called out at the start of the year, which is we've got a number of products that are very large, but are also early in their life cycle, eCOA, RTSM, EDC, Safety, LIMS....
— Brian Van Wagener, Q1 FY2027 earnings call

What analysts pressed on

Analysts expressed concerns regarding the conservative nature of the guidance increase, questioning whether it reflects underlying macroeconomic conditions or specific product challenges. There were also inquiries about the potential impact of AI on traditional roles within the industry.

Main topics on the call

Read the full Veeva Systems Inc. transcript (Q1 FY2027) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Veeva Systems Inc.

Veeva Systems Inc. (VEEV) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 55 calls on record spanning January 16, 2020 to June 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 55 Veeva Systems Inc. earnings call transcripts on record, spanning January 16, 2020 to June 3, 2026. Based on this history, Veeva Systems Inc. reports quarterly. The most recent call on file is dated June 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
VEEV
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Technology
Calls on record
55
First call
January 16, 2020
Most recent
June 3, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Jun 3, 2026 Read transcript
Q4 FY2026 Mar 4, 2026 Read transcript
Company Conference Presentations Jan 13, 2026 Read transcript
Company Conference Presentations Dec 8, 2025 Read transcript
Q3 FY2026 Nov 20, 2025 Read transcript
Analyst/Investor Day Oct 16, 2025 Read transcript
Company Conference Presentations Sep 4, 2025 Read transcript
Q2 FY2026 Aug 27, 2025 Read transcript
Company Conference Presentations Jun 3, 2025 Read transcript
Q1 FY2026 May 28, 2025 Read transcript
Q4 FY2025 Mar 5, 2025 Read transcript
Company Conference Presentations Jan 16, 2025 Read transcript
Company Conference Presentations Dec 11, 2024 Read transcript
Q3 FY2025 Dec 5, 2024 Read transcript
Analyst/Investor Day Nov 7, 2024 Read transcript
Company Conference Presentations Sep 4, 2024 Read transcript
Q2 FY2025 Aug 28, 2024 Read transcript
Company Conference Presentations Jun 6, 2024 Read transcript
Company Conference Presentations Jun 5, 2024 Read transcript
Q1 FY2025 May 30, 2024 Read transcript
Company Conference Presentations Mar 6, 2024 Read transcript
Q4 FY2024 Feb 29, 2024 Read transcript
Company Conference Presentations Jan 19, 2024 Read transcript
Company Conference Presentations Jan 10, 2024 Read transcript
Q3 FY2024 Dec 6, 2023 Read transcript
Analyst/Investor Day Nov 9, 2023 Read transcript
Company Conference Presentations Sep 6, 2023 Read transcript
Q2 FY2024 Aug 30, 2023 Read transcript
Company Conference Presentations Jun 8, 2023 Read transcript
Company Conference Presentations Jun 7, 2023 Read transcript
Q1 FY2024 May 31, 2023 Read transcript
Q4 FY2023 Mar 1, 2023 Read transcript
Company Conference Presentations Jan 11, 2023 Read transcript
Q3 FY2023 Dec 1, 2022 Read transcript
Analyst/Investor Day Nov 3, 2022 Read transcript
Q2 FY2023 Aug 31, 2022 Read transcript
Q1 FY2023 Jun 1, 2022 Read transcript
Q4 FY2022 Mar 2, 2022 Read transcript
Q3 FY2022 Dec 1, 2021 Read transcript
Analyst/Investor Day Oct 28, 2021 Read transcript
Q2 FY2022 Sep 1, 2021 Read transcript
Q1 FY2022 May 27, 2021 Read transcript
Q4 FY2021 Mar 2, 2021 Read transcript
Company Conference Presentations Jan 14, 2021 Read transcript
Shareholder/Analyst Calls Jan 13, 2021 Read transcript
Q3 FY2021 Dec 1, 2020 Read transcript
Analyst/Investor Day Oct 29, 2020 Read transcript
Q2 FY2021 Aug 27, 2020 Read transcript
Shareholder/Analyst Calls Jun 25, 2020 Read transcript
Company Conference Presentations Jun 10, 2020 Read transcript
Company Conference Presentations Jun 3, 2020 Read transcript
Q1 FY2021 May 28, 2020 Read transcript
Company Conference Presentations Mar 4, 2020 Read transcript
Q4 FY2020 Mar 3, 2020 Read transcript
Company Conference Presentations Jan 16, 2020 Read transcript